Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>FL R/R>*** > TREAT.: > USA. G. CD20xCD3 BiSpecific MAb> > (*) EU Approval Date: 2022. 06.09

---

(*) EU Approval Date: 2022. 06.09's products
This section has no products